BIOMARKER TESTING RATES AMONG PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER TREATED WITHIN LARGE COMMUNITY HEALTH SYSTEMS IN THE US

被引：0
|
作者：
Winzeler, A. [1 ]
Lorenzo, R. [1 ]
Pomerantz, D. [1 ]
Brown, T. [1 ]
Berry, A. [1 ]
机构：
[1] Syapse, San Francisco, CA USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD33
引用
收藏
页码：S582 / S582
页数：1
相关论文
共 50 条
  • [21] A retrospective study of maintenance pemetrexed in advanced non-squamous non-small cell lung cancer
    Oguh, L.
    Ranatunge, D.
    Lind, M.
    Ukadhyay, S.
    El-Mahdawi, N.
    [J]. LUNG CANCER, 2018, 115 : S30 - S30
  • [22] Implementation of a multidisciplinary quality improvement initiative to improve molecular testing rates in advanced non-squamous non-small cell lung cancer.
    Otaibi, Zachary
    Rao, Rohit
    Bartock, Matthew
    Gaddam, Mamatha
    Martin, Samantha A.
    Finley, Gene Grant
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [23] Maintenance chemotherapy in patients with non-squamous non-small cell lung cancer (NSCLC)
    Belalcazar, A.
    Santos, E. S.
    Gomez, J. E.
    Lopez, E.
    Raez, L. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Treatment algorithms for patients with metastatic non-small cell, non-squamous lung cancer
    Melosky, Barbara
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [25] REAL-WORLD BIOMARKER TESTING RATES AMONG PATIENTS WITH WITH ADVANCED NON-SMALL CELL LUNG CANCER IN THE UNITED STATES
    Vieira, M. C.
    Kelton, J. M.
    Lamarre, N.
    Abraham, A.
    Duncan, K.
    Krulewicz, S.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S437 - S437
  • [26] Predicting Survival in Patients with Advanced Non-squamous Non-small Cell Lung Cancer: Validating the Extent of Metastasis
    Lee, Dong Soo
    Kang, Jin Hyoung
    Lee, Chang Geol
    Kim, Seoung Jun
    Choi, Young Jin
    Lee, Kyo Young
    Kim, Yeon Sil
    [J]. CANCER RESEARCH AND TREATMENT, 2013, 45 (02): : 95 - 102
  • [27] Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
    Noor, Zorawar S.
    Goldman, Jonathan W.
    Lawler, William E.
    Telivala, Bijoy
    Braiteh, Fadi
    DiCarlo, Brian A.
    Kennedy, Kathleen
    Adams, Brad
    Wang, Xiaoyan
    Jones, Benjamin
    Slamon, Dennis J.
    Garon, Edward B.
    [J]. LUNG CANCER, 2019, 135 : 104 - 109
  • [28] Pemetrexed versus vinorelbine treatment of advanced non-squamous non-small cell lung cancer in elderly patients
    Chen, Yongshun
    Wen, Qinglian
    Liu, Hao
    Ao, Rui
    Wu, Xiaoyuan
    Guo, Leiming
    Wang, Wen
    He, Chunyu
    Wang, Jianhua
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (03) : 553 - 557
  • [29] Cost-Effectiveness of Pemetrexed for Advanced Non-Squamous Non-Small Cell Lung Cancer (nsNSCLC) in Patients Treated in a Spanish Institution
    Mielgo Rubio, Xabier
    Martinez Cabanes, Ruth
    Velastegui, Alejandro
    Rosero, Adriana
    Ruiz-Gimenez, Leticia
    Aguayo, Cristina
    Garcia Ferron, Maria
    Silva, Jorge
    Perez Fernandez, Elia
    Jara, Carlos
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S419 - S419
  • [30] Biomarker Testing and Associated Treatment patterns in Advanced Non-Small Cell Lung Cancer in the US
    Last, M.
    Burlison, H.
    Chandrasekar, S.
    Wong, C. Hooi
    Bailey, H.
    Forshaw, C.
    Foley, G.
    Duncan, K.
    Krulewicz, S.
    Wiltshire, R.
    Thomaidou, D.
    Iadeluca, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E26 - E26
12345